Sidonie Fabre Joins Advent France Biotechnology as CFO
CIOReview
CIOREVIEW >> Pharma & life sciences >>

Sidonie Fabre Joins Advent France Biotechnology as CFO

By CIOReview | Wednesday, June 16, 2021
CIOReview

Sidonie Fabre, CFO, Advent France Biotechnology

Sidonie Fabres' extensive career in finance helps Advent France Biotechnology (AFB) strengthen its financial structure.

FREMONT, CA: Advent France Biotechnology (AFB), an AMF-regulated investment firm dedicated to life sciences, appoints Sidonie Fabre as chief financial officer.

Sidonie Fabres' career as CFO spans 15 years in the investment industry, working for public and private companies. She was previously the chief financial officer of Crdit Agricole Régions Investissement. Sidonie began her career in finance as a sell-side analyst at CM-CIC Securities, then moved on to work as an asset manager at Covea Finance before taking on the role of receivership director for a court-appointed administrator. In addition, Sidonie worked as a business development manager in the engineering industry from 2012 to 2016. She holds a master's degree in finance from the University Paris Dauphine (Paris, France).

“I’m delighted to join AFB and its experienced team of investment experts. I’m truly fascinated by the biotech industry and its innovative startups. This is an exciting time for AFB, and I’m very happy to help the company achieve its growth goals during 2021 and beyond,” says Sidonie Fabre.

Sidonie will oversee all financial activities at AFB in her capacity as CFO. One of her primary responsibilities will be to develop a new vision for the company's economic structure and to provide a range of innovative solutions, including streamlining the reporting process to Limited Partners and regulatory authorities. Additionally, she will assist in promoting AFB to institutional investors.

“Sidonie is a multi-talented expert in business, financial and legal issues, and we are thrilled to welcome her to the AFB team. Our continued growth requires stronger financial organization and management; Sidonie will help us achieve that as we are preparing to raise our second fund,” says Alain Huriez, MD, AFB co-founder and chairman.